Medical economics

Sharing vaccines is in countries' best interests

How nations can best allocate COVID-19 vaccines remains a discussion of global importance. And at its heart is the question of whether countries with greater access to vaccines should focus on vaccinating their own citizens ...

Pediatrics

Kids need the COVID-19 jab for herd immunity

James Cook University scientists have developed a new model to track the COVID pandemic—and it's telling them Australia should now prioritize delivering the Pfizer vaccine to 12-40 year-olds.

Diseases, Conditions, Syndromes

Has Delta killed the herd immunity dream?

As the Delta variant continues its global surge, experts are questioning whether the long-held goal of achieving herd immunity from COVID-19 through vaccination is still viable.

Diseases, Conditions, Syndromes

How the Delta variant is changing the U.S. forecast for COVID-19

(HealthDay)—COVID-19 vaccines are helping protect the unvaccinated as the new Delta strain surges across the United States, but experts say its high infectiousness could mean even more people need to take the jab to achieve ...

Diseases, Conditions, Syndromes

COVID-19 herd immunity is not going to happen, so what next?

Any notion that COVID-19 was going to last for just a few months was very much misplaced in 2020. Especially after it was recognized that the SARS-CoV-2 virus was largely spread through the airborne route, all indications ...

Vaccination

Delta a new challenge for herd immunity

New modelling from James Cook University scientists shows Australia needs to vaccinate at least 85 percent of the population to achieve herd immunity.

Vaccination

HPV vaccine has a significant impact even if not universal

Human papillomavirus (HPV) vaccines applied in national vaccination programs protect against most cancers associated with oncogenic, high-risk (hr) HPV types. Two recent studies demonstrate the impact of gender-neutral HPV ...

page 4 from 14